The effect of COVID-19 on patients recieving omalizumab treatment
{{output}}
Background and aim: Although exposure during drug administration and susceptibility to coronavirus disease-19 (COVID-19) infection secondary to immunomodulatory effects constitute potential risks for patients with chronic spontan... ...
